articleNature MedicineJan 20, 2025Closed access

Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies

University of Pennsylvania · Children's Hospital of Philadelphia · +5 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

69
total citations
FWCI
55.24
Percentile
100%
References
90
Citations per year

Authors

66

Topics & keywords

Keywords
  • Genetic enhancement
  • Term (time)
  • Coronavirus disease 2019 (COVID-19)
  • Virology
  • Medicine
  • Gene
  • Computational biology
  • Biology
No related works found for this paper.